Stockscreener 앱 받기
3.35
1.47%
-0.05
시간 외 거래:
3.33
-0.02
-0.60%
Arbutus Biopharma Corp 주식(ABUS)의 최신 뉴스
News impact scoring models applied to Arbutus Biopharma CorporationMomentum-Based Prediction for Quick Returns - Newser
Arbutus Biopharma Corporation stock momentum explainedTrading Watchlist with Real Time Filters - Newser
Why Arbutus Biopharma Corporation stock attracts strong analyst attentionSafe Entry Screening with Data Backed Analysis - Newser
How to integrate Arbutus Biopharma Corporation into portfolio analysis toolsTrade Setup Builder with Custom Alerts - Newser
What moving averages say about Arbutus Biopharma CorporationFree Smart Money Tracking Signal Generator - Newser
Is Arbutus Biopharma Corporation stock reversal real or fakeStock Market Watch with Smart Filters - Newser
Arbutus Biopharma Corporation (NASDAQ:ABUS) Stock Position Decreased by Zurcher Kantonalbank Zurich Cantonalbank - Defense World
Applying big data sentiment scoring on Arbutus Biopharma CorporationTechnical Safety Zone Pattern Recognition - Newser
Arbutus Biopharma (NASDAQ:ABUS) Stock Rating Upgraded by Wall Street Zen - Defense World
Arbutus Biopharma Corporation stock outlook for YEARSecure Buy Strategy Based on Risk Parameters - Newser
Is now a turning point for Arbutus Biopharma CorporationFree Alpha Focused Technical Trade Signals - Newser
Is Arbutus Biopharma Corporation stock entering bullish territoryFree Community Strategy With High Win Rate - Newser
When is the best time to buy Arbutus Biopharma Corporation stockPortfolio Safety Metrics and Return Analysis - Newser
Arbutus Biopharma Returns to Profitability as It Regains Global Rights to Lead Hepatitis B Drug - MyChesCo
What risks could impact Arbutus Biopharma Corporation stock performanceLong Term Stock Growth Plan Suggestions - Newser
Arbutus: Q2 Earnings Snapshot - Connecticut Post
Arbutus Biopharma Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Arbutus Biopharma (ABUS) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Arbutus Biopharma earnings beat by $0.05, revenue topped estimates - Investing.com
Arbutus Biopharma Reports Q2 Earnings of $2.523mln, Revenue of $10.739mln, EPS of $0.01 - AInvest
Arbutus Biopharma Corp Reports Q2 2025 Earnings: EPS of $0.01 an - GuruFocus
Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Real time social sentiment graph for Arbutus Biopharma CorporationHigh Return Strategy with Low Risk - Newser
Arbutus Biopharma (ABUS) Projected to Post Earnings on Thursday - Defense World
Forecasting Arbutus Biopharma Corporation price range with options dataTriple Digit Gain Opportunity Watchlist - Newser
Arbutus Biopharma Corporation stock trendline breakdownMarket Timing Strategy with Technical Filters - Newser
What are the latest earnings results for Arbutus Biopharma CorporationBuild a diversified portfolio for steady growth - Jammu Links News
What are the technical indicators suggesting about Arbutus Biopharma CorporationTriple-digit returns - Jammu Links News
What data driven models say about Arbutus Biopharma Corporation’s futureShort Term High Yield Stock Tips for Active Traders - beatles.ru
Bank of New York Mellon Corp Decreases Holdings in Arbutus Biopharma Corporation (NASDAQ:ABUS) - Defense World
Technical analysis overview for Arbutus Biopharma Corporation stockFree Buy Low Sell High Stock Watch - Newser
Arbutus Biopharma Corporation Recovery Hinges on Volume BreakoutSecure Return Focused Investment Plan Released - metal.it
Published on: 2025-07-30 00:59:28 - Newser
Will breakout in Arbutus Biopharma Corporation lead to full recoveryFree Reliable Chart-Based Trade Entries - Newser
Published on: 2025-07-28 23:59:46 - beatles.ru
What catalysts could drive Arbutus Biopharma Corporation stock higher in 2025Consistently exceptional gains - Jammu Links News
Arbutus Biopharma Corp expected to post a loss of 5 cents a shareEarnings Preview - TradingView
Does Arbutus Biopharma Corporation stock perform well during market downturnsRapid market gains - jammulinksnews.com
When is Arbutus Biopharma Corporation stock expected to show significant growthConsistent triple returns - Jammu Links News
How strong is Arbutus Biopharma Corporation company’s balance sheetInvest in stocks with strong fundamentals - Jammu Links News
What institutional investors are buying Arbutus Biopharma Corporation stockDiscover stocks with massive upside potential - Jammu Links News
Published on: 2025-07-28 03:47:36 - jammulinksnews.com
Is Arbutus Biopharma Corporation Stock a Smart Buy in 2025 Investment Analysis InsideVerified Return Tips - Newser
1.02%
3.70%
자본화:
|
볼륨(24시간):